Impact of daily plan adaptation on organ-at-risk normal tissue complication probability for adrenal lesions undergoing stereotactic ablative radiation therapy-Reference-Cited by-同舟云学术

Impact of daily plan adaptation on organ-at-risk normal tissue complication probability for adrenal lesions undergoing stereotactic ablative radiation therapy

Published:2021-10 Issue: Volume:163 Page:14-20
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Chen Hanbo,Schneiders Famke L.,Bruynzeel Anna M.E.,Lagerwaard Frank J.,van Sörnsen de Koste John R.,Cobussen Paul,Bohoudi Omar,Slotman Berend J.,Louie Alexander V.,Senan Suresh

Funder

International Association for the Study of Lung Cancer

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference40 articles.

1. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial;Palma;Lancet,2019

2. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials;Chang;Lancet Oncol,2015

3. Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial;Brand;Lancet Oncol,2019

4. Stereotactic body radiation therapy of adrenal metastases: a pooled meta-analysis and systematic review of 39 studies with 1006 patients;Chen;Int J Radiat Oncol Biol Phys,2020

5. The Canadian Association of Radiation Oncology scope of practice guidelines for lung, liver and spine stereotactic body radiotherapy;Sahgal;Clin Oncol (R Coll Radiol),2012

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Outcomes of Online Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Adrenal Metastases from a Single Institution;Cancers;2024-06-19

2. Factors influencing local control after MR-guided stereotactic body radiotherapy (MRgSBRT) for adrenal metastases;Clinical and Translational Radiation Oncology;2024-05

3. Effect of synthetic CT on dose-derived toxicity predictors for MR-only prostate radiotherapy;BJR|Open;2023-12-12

4. Clinical outcomes of MR-guided adrenal stereotactic ablative radiotherapy with preferential sparing of organs at risk;Clinical and Translational Radiation Oncology;2023-11

5. Tumor volume changes during stereotactic ablative radiotherapy for adrenal gland metastases under MRI guidance;Radiotherapy and Oncology;2023-09